Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2141808
                    [Title] => Philippines wins global science competition
                    [Summary] => The Philippines won the first-ever Global Innovation through Science and Technology Catalyst Pitch competition given by the US Department of State with its Philippine-based startup Galansiyang, placing first in two categories.
                    [DatePublished] => 2021-11-17 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804865
                    [AuthorName] => Pia Lee-Brago
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 700713
                    [Title] => Novartis partners with TMC to enhance  gastrointestinal stromal tumor mg't
                    [Summary] => 
Research-based health care company Novartis has partnered with The Medical City (TMC) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
                    [DatePublished] => 2011-06-30 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 698526
                    [Title] => Novartis partners with NKTI to enhance  mg't of gastrointestinal stromal tumor
                    [Summary] => 
Research-based health care company Novartis has partnered with the National Kidney and Transplant Institute (NKTI) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
                    [DatePublished] => 2011-06-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 464588
                    [Title] => Reducing risk of cancer returning in patients
                    [Summary] => 
MANILA,  Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.
                    [DatePublished] => 2009-05-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

GIST

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2141808
                    [Title] => Philippines wins global science competition
                    [Summary] => The Philippines won the first-ever Global Innovation through Science and Technology Catalyst Pitch competition given by the US Department of State with its Philippine-based startup Galansiyang, placing first in two categories.
                    [DatePublished] => 2021-11-17 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804865
                    [AuthorName] => Pia Lee-Brago
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 700713
                    [Title] => Novartis partners with TMC to enhance  gastrointestinal stromal tumor mg't
                    [Summary] => 
Research-based health care company Novartis has partnered with The Medical City (TMC) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
                    [DatePublished] => 2011-06-30 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 698526
                    [Title] => Novartis partners with NKTI to enhance  mg't of gastrointestinal stromal tumor
                    [Summary] => 
Research-based health care company Novartis has partnered with the National Kidney and Transplant Institute (NKTI) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.
                    [DatePublished] => 2011-06-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 464588
                    [Title] => Reducing risk of cancer returning in patients
                    [Summary] => 
MANILA,  Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.
                    [DatePublished] => 2009-05-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Philippines wins global science competition

By Pia Lee-Brago | November 17, 2021 - 12:00am

The Philippines won the first-ever Global Innovation through Science and Technology Catalyst Pitch competition given by the US Department of State with its Philippine-based startup Galansiyang, placing first in two...

Headlines

Novartis partners with TMC to enhance gastrointestinal stromal tumor mg't

June 30, 2011 - 12:00am

Research-based health care company Novartis has partnered with The Medical City (TMC) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.

Science and Environment

Novartis partners with NKTI to enhance mg't of gastrointestinal stromal tumor

June 23, 2011 - 12:00am

Research-based health care company Novartis has partnered with the National Kidney and Transplant Institute (NKTI) to enhance the diagnosis and treatment of gastrointestinal stromal tumor (GIST) in the country.

Science and Environment

Reducing risk of cancer returning in patients

May 7, 2009 - 12:00am

MANILA, Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal...

Science and Environment